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1. Introduction 
Human embryonic stem cells (hESCs) are culture-adapted cells that were originally derived 
from the inner cell mass (ICM) of the blastocyst-stage embryo [1]. HESCs are pluripotent 
cells that can be propagated indefinitely in culture, while retaining the in vivo properties of 
ICM cells; they can give rise to all tissues of the three germ layers (ectoderm, mesoderm and 
endoderm). Due to their pluripotency, hESCs have been the subject of intense research since 
they were initially isolated in 1998. HESCs can serve as model systems to study early human 
development, in addition to providing a potentially unlimited source of functional tissues 
for use in drug evaluation and regenerative medicine. Nevertheless, despite major advances, 
the exact molecular mechanisms that govern the self-renewal and differentiation of hESCs 
remain unclear. Indeed, a mechanistic understanding of the molecular processes regulating 
hESC fate can elucidate early events in human development and enable the development of 
protocols for efficient generation of functional tissues. Here we review the molecular 
mechanisms that regulate hESC fate; specifically, we focus on the role of signaling pathways 
and factors regulating epigenetic changes, in hESC self-renewal and lineage-specific 
differentiation. 
In hESCs, as in embryos, differentiation is triggered by developmental cues such as 
morphogens or cytokines that are present in the extracellular space. These morphogens or 
cytokines bind to their cognate plasma membrane-bound receptors and activate specific 
signaling pathways inside the cell. Activation of signaling pathways involves a sequence of 
phosphorylation events that eventually result in the regulation of specific transcription 
factors. These transcription factors, in turn, can recruit other co-factors and directly cause 
transcription of downstream genes. Furthermore, transcription factors can recruit histone 
modifying and chromatin remodeling enzymes to reshuffle the epigenetic structure, such 
that pluripotency genes become inaccessible for transcription and are repressed, whereas 
lineage-specific genes become accessible and are activated. This sequence of events finally 
leads to expression of lineage-specific proteins such as transcription factors and structural 
proteins, causing a morphological change in the cell. Also, pluripotency associated 
transcription factors and other pluripotency-associated genes are permanently repressed, 
thereby completing the process of differentiation. Thus, the process of differentiation is a 
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rather complex cascade of events, controlled by signaling pathways, transcription factors, 
epigenetic factors and lineage-specific proteins. While significant understanding of each of 
these functional groups (i.e., signaling pathways, transcription factors, epigenetic factors 
and lineage-specific proteins) has been gathered in isolation, very little is known about the 
interactions amongst these groups, particularly in the context of hESC differentiation. In 
part, interactions amongst these groups confer lineage specificity to the process of 
differentiation and mediate the development of specific tissues upon exposure of hESCs to 
certain morphogens. In this review, we focus on the role of signaling pathways, 
transcription factors and epigenetic factors in the context of lineage-specific differentiation 
of hESCs and summarize the various links between these groups. Our goal is to present a 
mechanistic overview of the sequence of molecular events that regulate the differentiation of 
hESCs along various lineages.  
2. The signaling pathways 
As briefly described earlier, the self-renewal and differentiation of hESCs is governed by 
several developmental cues. The most well known among these are cytokines that trigger 
specific signaling pathways. These extracellular ligands initiate signaling through 
interactions with ligand-specific cell surface receptors. Receptor-binding typically results in 
association of multiple receptor subunits and activation of the kinase domains of receptors 
or other receptor-bound effector proteins. This triggers a sequence of phosphorylation 
events involving various other proteins, finally resulting in the activation or inhibition of 
transcription factors. These transcription factors in turn are directly responsible for 
activating or repressing their target genes. Thus, a group of signaling pathways is usually 
responsible for modulating gene expression in hESCs, leading to control of the 
transcriptome, the proteome and ultimately cellular physiology. In this section, we 
summarize key signaling pathways that have been implicated in the maintenance of 
undifferentiated hESCs and their lineage-specific differentiation.  
2.1.1 The transforming growth factor-β pathway 
The transforming growth factor  (TGF-) pathway is well known for its involvement in 
embryonic development and patterning, as well as in epithelial-to-mesenchymal 
transformations and carcinogenesis [2-3]. This pathway (extensively reviewed elsewhere [2, 
4-5]) is divided into two branches: the Activin/Nodal branch and the Bone Morphogenetic 
Protein (BMP) branch. The Activin/Nodal pathway is activated by ligands such as Activin, 
Nodal and TGF1. These ligands bind to their Type II receptor, which then recruits the Type 
I receptor. The Type II receptor phosphorylates the intracellular domain of the Type I 
receptor, creating a binding site for SMAD2 and SMAD3 transcription factors. Upon 
binding, SMAD2/3 is phosphorylated by the Type I receptor, leading to subsequent 
dissociation of SMAD2/3. Phosphorylated SMAD2/3 then associates with SMAD4 and can 
enter the nucleus to modulate gene expression. The BMP branch is activated by the BMP 
ligands; binding of BMP ligands results in phosphorylation of the type I receptor by the type 
II receptor, and subsequent intracellular binding and phosphorylation of SMAD1/5/8. 
Phosphorylated SMAD1/5/8 forms a complex with SMAD4 and subsequently enters the 
nucleus. Unlike ligands in the Activin/Nodal branch, the BMPs have high affinities for the 
type I receptor and bind weakly to the type II receptor; Activin/Nodal bind with high 
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affinity to their type II receptors and do not directly interact with their type I receptors. 
Numerous other proteins can modulate the localization and activity of SMADs (reviewed in 
[6-8]). Additionally, the activated TGF pathway receptors can also activate the Mitogen 
Activated Protein Kinase (MAPK) Pathway [9]. 
2.1.2 Role in lineage determination 
The TGF pathway plays a significant role during embryogenesis across many species 
including flies, fishes, amphibians and mammals (reviewed in [10]). Specifically among 
vertebrates, Nodal is expressed throughout the epiblast [11] and is required for specification 
of mesoderm and endoderm from the epiblast [12]. Low levels of Nodal lead to mesoderm 
formation whereas high levels lead to endoderm formation [13]. Absence of Nodal signaling 
through active inhibition leads to ectoderm formation [12, 14]. Within the ectoderm, high 
levels of BMP cause formation of epidermis while low levels cause neural plate formation 
[15]. Intermediate levels of BMP lead to neural crest formation at the borders of the neural 
plate, although this a necessary but not a sufficient condition [16].  
Not surprisingly, in vitro protocols for differentiating hESCs resemble in vivo conditions 
present during embryogenesis. Specifically, Activin causes endoderm differentiation from 
hESC cultures, while Activin and BMP simultaneously lead to mesoderm formation [17-21]. 
Inhibition of both Activin/Nodal and BMP causes neural differentiation [22] and this 
differentiation proceeds through an epiblast-like intermediate. Intriguingly, some amount of 
Activin/Nodal signaling is essential for hESC pluripotency; the pluripotency factor Nanog 
is a direct target of Smad2/3 [23-25] and inhibition of Activin/Nodal causes upregulation of 
BMP and subsequent trophectoderm differentiation [26]. Short term BMP treatment causes 
mesoderm formation [27] whereas long term BMP treatment leads to trophectoderm 
formation [28]. The disparity of BMP treatment leading to trophectoderm differentiation and 
not epidermal differentiation, as during embryogenesis, can in part be attributed to the fact 
that hESCs are derived from ICM cells and not epiblast cells. Thus, even though in vivo 
embryogenesis serves to provide guidelines for carrying out in vitro differentiation of 
hESCs, major challenges still remain. The biggest of these challenges is perhaps the 
heterogeneity in lineages of differentiated cells obtained through most in vitro protocols. 
This is primarily because most differentiation protocols rely on embryoid body (EB) 
formation which results in a heterogeneous environment for cells within the EB, and leads 
to heterogeneity in the lineages obtained after differentiation. Another challenge is the 
inability to form an absolute mechanistic link between the culture conditions used to 
differentiate hESCs, and the differentiation behavior seen in hESCs. This is mostly because 
the composition of serum, B27, serum replacer, conditioned medium and other components 
of media used for differentiation studies, are unknown [29].  
2.2.1 The Fibroblast Growth Factor pathway 
The Fibroblast Growth Factor (FGF) pathway is also known for its involvement in 
embryonic development and patterning, as well as in regulation of cell growth, proliferation 
and motility (extensively reviewed in [30-34]). The FGF pathway is activated when the FGF 
ligands, which have a strong affinity for Heparan Sulfate Proteoglycans (HSPGs), bind to 
FGF Receptors (FGFRs) forming a 2:2:2 combination of FGF: FGFR: HSPG on the cell 
surface. The ensuing receptor dimerization causes transphosphorylation of tyrosine residues 
in the intracellular domains of FGFRs through their tyrosine kinase domains. The 
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phosphorylated tyrosines of FGFRs cause recruitment of the GRB2/SOS complex and its 
subsequent activation. SOS then activates RAS, which triggers the MAPK cascade, finally 
leading to the activation of extracellular-signal related kinases (ERKs). Activated Erk1/2 can 
phosphorylate and control the activity of a wide range of proteins [35]. Notably, Erk1/2 can 
phosphorylate the linker region of SMAD1 and inhibit BMP signaling [36-37]. Additionally, 
activated FGF receptors can also recruit FRS2/GRB2 and activate them, leading to 
recruitment of GAB1. GAB1 activates the Phosphatidylinositol 3-kinase (PI3K) pathway. 
Thus, FGF can also activate the PI3K pathway in a cell-specific context. 
2.2.2 Role in lineage determination 
The FGF pathway is needed for proper embryonic development in vertebrates. Experiments 
in mice have shown that FGF4 is required for ICM proliferation and maintenance [38-39], 
and for trophectoderm and primitive endoderm development [40]. FGF4 is secreted by the 
ICM and supports trophectoderm maintenance [41]. Interestingly, activation of HRas1 
which is a component of the MAPK pathway, in mouse embryonic stem cells (mESCs) 
caused upregulation of Cdx2, a trophectoderm marker, and trophectoderm stem cells were 
derived from these mutants [42]. FGF4 secreted by ICM also causes primitive endoderm 
differentiation [43]. Further along the developmental timeline, FGF signaling is required for 
the induction of paraxial mesoderm and for maintenance (but not induction) of axial 
mesoderm [44-46]. FGF is required for primitive streak formation and cell migration during 
gastrulation [45, 47]. Inhibition of FGF is required for blood development [48-50], whereas 
activation of FGF signaling is required for neural differentiation [51]. However the 
mechanism by which FGF aids in embryonic neural differentiation is not fully understood 
[52-53]. In vitro studies have mimicked the role of FGF signaling in hESC maintenance and 
differentiation. FGF2 is required for maintaining hESCs in a pluripotent state [24, 54-55]. 
FGF signaling is also required for maintenance of mouse trophectoderm stem cells which 
are derived from the trophectoderm tissue of mouse embryos [56]. While there are no 
specific studies which delineate the inductive and maintenance/proliferative roles of FGF 
during hESC differentiation, work with mESCs have given ambiguous results, some 
showing that autocrine FGF2 is essential for neural differentiation [57] while others showing 
that FGF2 has a role in maintenance rather than induction of neural differentiation [58-59]. 
However, FGF signaling does seem to be necessary for inducing the posterior nervous 
system in vertebrate embryos [53, 60].  
2.3.1 The Wnt pathway 
The Wnt pathway is widely implicated during various stages of embryonic development, 
homeostasis as well as in cancer. This pathway (reviewed in [61-62]) has canonical and non-
canonical branches. The canonical Wnt pathway is activated by binding of Wnt ligands to 
the Frizzled receptors and low-density lipoprotein receptor-related protein 5/6 (LRP5/6) co-
receptors leading to the recruitment of Dishevelled to the Frizzled receptor. This causes 
recruitment of Axin to the receptor complex, causing the subsequent deactivation of Axin. In 
the absence of Wnt signaling, Axin associates with GSK3, adenomatous polyposis coli 
(APC), casein kinase 1 (CK1) and -catenin. CK1 and GSK3 phosphorylate -catenin 
causing it to be degraded. Upon Wnt activation, Axin is inhibited and -catenin becomes de-
repressed, and subsequently enters the nucleus to function as a transcription factor. Various 
co-factors associate with -catenin and control its promoter specificity, thus dictating the 
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target genes activated or repressed by -catenin [63-64]. The non-canonical Wnt pathway 
acts independently of -catenin and is also required during embryogenesis. The details of 
this Ca2+-dependent pathway are reviewed in [62]. 
2.3.2 Role in lineage determination 
The canonical Wnt pathway is activated during gastrulation [65] and mutation of Wnt3 
blocks primitive streak formation resulting in lack of mesoderm and endoderm [66] (the 
primitive streak-specific transcription factor Brachyury is a direct target of Wnt3a signaling 
[67]). Similar defects are seen in Lrp5/6 double mutants and -catenin loss-of-function 
mutants [68-69]. Interestingly, expression of Cripto, a co-receptor for Nodal signaling, is 
missing in -catenin loss-of-function mutants [70]. Also, -catenin is indispensable for 
endoderm formation and loss of -catenin causes definitive endoderm to change into pre-
cardiac mesoderm [71]. Although loss of Wnt signaling leads to loss of mesoderm 
formation, inhibition of Wnt signaling is required for a cardiac fate [65, 72], once pre-cardiac 
mesoderm has been induced. Remarkably, similar reports for the role of Wnt signaling have 
been obtained through in vitro differentiation studies in hESCs. Over-expression of -catenin 
in hESC cultures lead to primitive streak formation [73]. Inputs form Activin/Nodal and 
BMP pathways are necessary for further lineage specification into mesoderm/endoderm. 
Blocking BMP signaling abolishes mesoderm and leads to endoderm formation, whereas 
Activin/Nodal is required for endoderm formation [73]. Wnt is required for mesoderm 
differentiation but must be inhibited thereafter for cardiac mesoderm formation [74]. 
2.4 The Phosphatidylinositol-3Kinase pathway 
The Phosphatidylinositol-3Kinase (PI3K) pathway regulates cell survival, apoptosis and has 
been implicated in cancer. The pathway as well as its role in cancer is reviewed in [75-78]. It 
also has been, in select cases, implicated in lineage-specific hESC differentiation [79]. The 
pathway is activated when PI3K is phosphorylated; this can happen through binding of 
Insulin to the Insulin receptor or of Insulin-like growth Factor (IGF) to Insulin-like Growth 
Factor Receptor (IGFR), or as previously discussed, by recruitment and activation of GAB1 
by FGFR. Activated PI3K phosphorylates Phosphatidylinositol (4, 5)-biphosphate to 
Phosphatidylinositol (3, 4, 5)-triphosphate and creates a docking site for proteins with a 
pleckstrin homology (PH) domain, such as Akt. Once Akt is properly docked, it is 
phosphorylated and activated by protein-dependent kinase 1 (PDK1). Akt can then 
dissociate and activate/repress numerous proteins by phosphorylating them [80]. The PI3K 
pathway has not received much attention during vertebrate embryogenesis, though some 
recent studies have emerged to show that it is necessary for normal embryo development 
[81-82]. Homozygous null mutations in the p110ǃ subunit of PI3K cause embryonic lethality 
before formation of the blastocyst [83]. Thus, in vivo studies do not implicate PI3K signaling 
in differentiation of cells, but rather in maintenance of cell viability [82]. It has been 
hypothesized that growth factors maintain PI3K signaling during embryogenesis to guard 
against ectopic or metastatic growth of cells, since such ectopic/metastatic cells do not 
receive enough growth factors and enter the default apoptotic pathway [84]. In contrast, in 
vitro studies with hESCs have shown some supportive role for the PI3K pathway in 
definitive endoderm differentiation. Inhibition of PI3K signaling enhances definitive 
endoderm differentiation by Activin [85]. Other conflicting reports show that PI3K signaling 
stabilizes -catenin during definitive endoderm formation [73]. A major challenge in 
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elucidating the possible role of this pathway during differentiation is the inability to 
decouple its role in cell viability. Therefore, careful studies need to be designed to assess the 
extent of its role in causing differentiation. 
2.5 The Hippo pathway 
So far we have focused on developmental cues in the form of morphogens, i.e. protein 
ligands that physically diffuse through the embryonic tissue and pattern the embryo. 
Another developmental cue that has recently emerged to be of significant importance 
during embryogenesis is cell-cell contact. An increase in cell-cell contact is sensed by the cell 
through the activation of the Hippo pathway (reviewed in [86-87]). The Hippo pathway is 
important for organ size control, tumorigenesis, epithelial-to-mesenchymal transformation 
and cell-cell contact inhibition. Although the molecular mechanisms of cell-cell contact 
sensing are not fully understood, an increase in cell-cell contact is known to ultimately lead 
to phosphorylation of MST1/2 kinases. They then associate with SAV1 and phosphorylate 
the LATS1/2 kinases. Upon phosphorylation, LATS1/2 kinases recruit MOB1 and 
phosphorylate YAP and TAZ, both of which are homologues with non-redundant functions 
[86, 88]. Phosphorylation of TAZ and YAP leads to their association with 14-3-3 proteins and 
subsequent cytoplasmic retention [89-90]. YAP and TAZ act as co-factors for various 
transcription factors such as TEADs, RUNX, PAX3 and SMAD1/2/3/7 and modulate their 
nuclear localization and/or activity [91-96]. Additionally, TAZ can associate with DVL2 and 
inhibit its phosphorylation by CK1, thus possibly inhibiting -catenin activation by Wnt 
factors [97]. Therefore, the nucleocytoplasmic shuttling of YAP and/or TAZ can lead to 
changes in the activity levels of associating transcription factors, leading to differentiation 
[93]. Indeed, low cell-cell contact at the periphery of the embryo leads to Yap activation, 
which in concert with Tead4, leads to trophoblast differentiation in mouse blastocysts [98]. 
The inner cell mass and epiblast tissues show predominantly cytoplasmic and weakly 
nuclear localization for Yap, Taz and phospho-Smad2 [98-99], in agreement with the fact 
that Taz controls Smad2 localization [93]. While cells of the mouse ICM continue to 
differentiate, in vitro cultures derived from ICM (i.e. mESCs) maintain high levels of Yap. 
Yap is downregulated during in vitro mESC differentiation and upregulated in mouse and 
human induced pluripotent stem (iPS) cells [100]. Ectopic Yap expression maintains mESC 
phenotype even under differentiation conditions. Though it remains to be seen whether 
downregulation of Yap/Taz is the cause of differentiation of ICM cells in vivo, experiments 
with hESCs show that downregulation of TAZ initiates neural differentiation [93]. Tead and 
Yap suppress terminal neuronal differentiation and maintain neural progenitor populations 
in the vertebrate neural tube [94]. Tead2 and Yap activate Pax3 expression during neural 
crest formation [101]. Tead1/2 and Yap also maintain the notochord which is formed from 
the axial mesoderm [102]. Thus the co-activators YAP and TAZ are important for the activity 
of many transcription factors during embryogenesis. However, further studies are needed to 
uncover the specific inductive/maintenance roles of these co-factors and their 
responsiveness to Hippo signaling in these tissues. 
2.6 Crosstalk between signaling pathways 
There is a vast amount of crosstalk between the various pathways described here, thus 
adding additional complexity in the regulation of downstream transcription factors [103]. 
As described earlier, the TGF-ǃ pathway can activate the MAPK pathway directly 
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downstream of receptor activation [9]. Both TGF-ǃ and FGF pathways can activate the PI3K 
pathways directly at the receptor level [9, 30]. However, the crosstalk between pathways is 
cell-specific, since the available pool of interacting proteins depends on the cell-type. Also, 
the promoter accessibility of downstream genes is dependent on cell-type. Therefore, here 
we restrict our discussion to crosstalk events identified specifically in hESCs. Activin/BMP 
signaling induces Wnt ligand expression in hESCs [74]. Also, Activin regulates FGF, Wnt 
and BMP pathways in hESCs [104]. Inhibition of Activin/Nodal signaling causes 
downregulation of Wnt3, FGF2, FGF4 and FGF8 expression [26] and upregulation of BMP 
signaling [26] while activation of Activin signaling causes upregulation of Wnt3 and FGF8 
expression [104]. Interestingly, upregulation of Activin signaling also causes upregulation of 
Nodal and Lefty expression. Cerberus1, an inhibitor of Nodal signaling, is a downstream 
target of both Wnt and Nodal pathways in hESCs [105]. Expression of Cripto, a co-activator 
of Nodal signaling, is upregulated by FGF signaling in hESCs [24]. As described earlier, 
YAP, which is regulated by the Hippo pathway, controls the nuclear localization of Smad2 
in hESCs [93]. Thus, it can be seen that hESCs exhibit considerable endogenous signaling 
wherein, signaling pathways not only control their own ligand expression but also the 
expression of ligands of other pathways.  
3. Other regulators of differentiation 
While morphogens and other developmental cues act as the environmental input to hESCs 
and trigger the process of differentiation, the molecular mechanisms responsible for 
carrying out differentiation inside the cell are complex and require many key factors. These 
factors are required for the following: 1) to bring about a change in gene expression which 
causes the cell to transition into the new lineage-specific physiology, 2) to reshuffle the 
epigenetic structure of the genome, and finally 3) to make the new epigenetic structure 
permanent, lending stability to the newly formed cellular physiology. We will now discuss 
these intracellular factors that mediate various aspects of the differentiation process. 
3.1 MicroRNAs 
MicroRNAs (miRNAs) have emerged as a new paradigm for regulating gene expression at 
the post-transcriptional level. The role of miRNAs in embryogenesis, stem cell fate and 
cancer is reviewed in [106-108]. Transcription factors regulate promoter regions of miRNAs, 
which upon synthesis can target many mRNAs and lead to downregulation of protein 
synthesis. MiRNAs, which upon transcription are called pri-miRNAs, fold into secondary 
structures with characteristic hairpin-loops. These are recognized by Drosha, which cleaves 
the hairpin-loop structures to generate pre-miRNAs. Pre-miRNAs are then exported to the 
cytoplasm and recognized by Dicer, which cleaves one of the strands and incorporates the 
other into the RNA-induced silencing complex (RISC). Once incorporated into RISC, the 
single-stranded miRNA recognizes target mRNAs (usually many different mRNA targets) 
through partial sequence complimentarily, and causes down-regulation of protein synthesis. 
It is now known that miRNAs play an important role in embryogenesis [109] and lineage-
determination, and that many lineages have their characteristic miRNA expression patterns, 
akin to characteristic mRNA expression patterns [110]. The role of miRNAs in 
embryogenesis is evident from the fact that Dicer mutant mouse embryos die during 
gastrulation [111], while Dicer deficient zebrafish embryos do not develop beyond day8 
[109]. The role of miRNAs in embryonic stem cell pluripotency and differentiation has also 
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been demonstrated recently [107]. Dicer deficient mESCs fail to differentiate in vitro as well 
as in vivo [112]. Over-expression of miR-302 leads to reprogramming of human hair follicle 
cells and human skin cancer cells to form iPS cells [113-114]. During mESC differentiation, 
miR-134, miR-296 and miR-470 target and downregulate the transcription factors Nanog, 
Sox2 and Oct4 [115]. MiR-200c, miR-203 and miR-183 target and repress Sox2 and Klf4, both 
of which are involved in maintaining pluripotency in mESCs [116]. Similarly, during hESC 
differentiation, miR-145 targets and represses OCT4, SOX2 and KLF4 [117]. Sall4, another 
pluripotency-related transcription factor, is positively regulated by the ESC cell cycle 
regulating (ESCC) family of miRNAs and negatively regulated by the let7 family [118]. 
Additionally, miRNAs are also implicated during later stages of differentiation. The muscle-
specific miR-1 controls cardiomyocyte differentiation and proliferation in mice by targeting 
the Hand2 transcription factor [119]. miR-181 controls hematopoietic differentiation in mice 
[120] and miR-143 regulates adipocyte differentiation [121]. MiR-196 is involved in HOX 
gene regulation [122-124] and the miR-200 family regulates olfactory neurogenesis [125]. 
MiRNAs have also been implicated in skin morphogenesis [126]. Most intriguingly, 
transfection of muscle-specific miR-1 or brain-specific miR-124 into human HeLa cells shifts 
the mRNA expression profile towards that of muscle or brain cells, respectively [127].  
The expression of miRNAs is regulated by transcription factors which bind promoter 
regions of genes harboring miRNAs; more than half of known mammalian miRNA genes 
are within host gene introns and are spliced after transcription [128]. For example, Activin A 
signaling regulates the expression of ~12 miRNAs in hESC cultures [129]. OCT4, NANOG 
and SOX2 occupy the promoter regions of ~14 miRNAs in hESCs [130]. Additionally, 
miRNAs can be regulated directly by signaling pathways. In smooth muscle cells, BMP4 or 
TGF-ǃ signaling causes increased processing of pri-miR-21 and pri-miR-199a [131] and 
regulates the processing of numerous other miRNAs [132]. The MAPK/ERK pathway can 
regulate miRNA maturation in the cytosol by controlling phosphorylation of TRBP, which 
functions with Dicer [133]. However, it is largely accepted that miRNAs do not trigger 
differentiation but rather, are required for carrying out the process of differentiation [107]. It 
is hypothesized that miRNAs are required to dampen the stochastic noise in mRNA 
transcription levels of genes during the process of differentiation. Thus, miRNAs add 
another layer of complexity to gene regulation during the process of differentiation, by fine-
tuning active mRNA levels of a gene. 
3.2 Epigenetic factors 
Our discussion on signaling pathways focused on how a change in gene expression during 
differentiation is initiated; while miRNAs are most probably required to stabilize the mRNA 
levels against stochastic perturbations during differentiation. However, to provide long-
term stability to the new gene expression pattern, the epigenetic structure of the genome 
needs to be changed. Epigenetic factors are responsible for modulating the epigenetic 
structure of hESCs, while it is pluripotent (reviewed in [134]) as well as while it goes 
through differentiation. The epigenetic structure of the genome dictates the promoter 
regions that would be accessible to transcription factors for initiating transcription; the 
heterochromatin, being densely packed, is inaccessible whereas the euchromatin is loosely 
packed and readily accessible. The epigenetic structure of hESCs is different from that of 
differentiated cells. The epigenetic structure also differs across various lineages of 
differentiation. Thus, epigenetic factors are involved in changing the epigenetic structure of 
the genome in a lineage-dependent fashion. 
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Epigenetic factors comprise broadly of histone modifying enzymes and chromatin 
remodeling complexes. The concerted action of both is needed to bring a stable change in 
the epigenetic landscape. Histone modifying enzymes are enzymes that modify histones 
post-translationally and create an epigenetic code of various acetylations, ubiquitinations 
and methylations throughout the genome (the histone code hypothesis [135-136]). This code 
is then recognized by chromatin remodeling enzymes, which alter the higher order structure 
of nucleosomes by creating heterochromatin and euchromatin. By controlling the formation 
of heterochromatin and euchromatin, these epigenetic factors control promoter accessibility 
and gene expression during differentiation. Differentiation is thought to proceed through 
activation of lineage-specific genes and repression of pluripotency genes [137]. This requires 
epigenetic factors to create repressive histone modifications on pluripotency genes (which 
were hitherto active) and reciprocally, to create activating histone modifications on lineage-
specific genes (which were hitherto repressed). Permanent modification of histones also 
allows for epigenetic stability of the differentiated cell, which now becomes locked in this 
lineage. There is also some feedback from chromatin remodeling enzymes back to histone 
modifying enzymes. This means that certain chromatin remodeling enzymes can recruit 
back specific histone modifying enzymes for changing the histone code further. This is 
thought to provide more robustness to this system of epigenetic modification, thus lending 
further stability to the differentiated phenotype. 
3.2.1 Histone Acetyltransferases 
Of the various histone modifications, acetylation and methylation are critical for regulating 
the chromatin structure and gene expression [138]. These histone modifications, which 
create the genome-wide histone code, are regulated by Histone Acetyltransferases (HATs), 
Histone Deacetylases (HDACs), Histone Methyltransferases (HMTs) and Histone 
Demethylases. Histone Acetyltransferases are further classified into five families [139-140]: 
the Gcn5-related HATs (GNATs); the MYST (MOZ, Ybf2/Sas3, Sas2 and Tip60)-related 
HATs; p300/CBP HATs; general transcription factor HATs; and nuclear hormone-related 
HATs. In humans, the identified GNAT-related HAT complexes are PCAF, STAGA and 
TFTC. All three complexes have the chromatin-binding bromodomain which targets these 
complexes to chromatin. The bromodomain specifically recognizes and binds acetylated 
histones [141-142]. In mammals, the identified MYST-related HATs are Moz, Qkf, Mof, 
Tip60 (homologue of yeast NuA4 [143]) and Hbo1. The TIP60 complex contains the 
chromatin-binding chromodomain. The chromodomain of yeast SAGA HAT complex has 
been shown to recognize methylated histones [144] raising the possibility that TIP60 may 
also be recruited to methylated histones in humans. Together with the case of the 
bromodomain containing complexes, this implies that HATs may be recruited to specifically 
tagged histones and may function in a signaling cascade to modify the epigenetic map of the 
genome [145]. Mof homozygous null mice lack H4K16 acetylation and arrest at blastocyst 
stage [146]. Homozygous null Tip60 mutant mice also die during blastocyst stage[147]. Tip60 
has also been implicated in pluripotency of ESCs [148]. Qkf is required for normal 
development of neurons of the cerebral cortex [149], whereas Moz is required for normal 
hematopoietic stem cell development [150-152]. 
3.2.2 Histone Deacetylases 
The family of Histone Deacetylases is classified into four groups [153-155]: the Class I 
HDACs (yeast Rpd3-like) comprising of HDAC1/2, HDAC3 and HDAC8; the Class II 
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HDACs (yeast Hda1-like) comprising of HDACs4-7, HDAC9 and HDAC10; the Class III 
HDACs (Sir2-like) comprising of SIRT1-7; and the Class IV HDACs (HDAC11-like) 
comprising of HDAC11. Of these, HDAC1 and HDAC2 have been identified in numerous 
complexes [156], namely: the SIN3 co-repressor complex, the nucleosome remodeling and 
deacetylase (NuRD) complex, the CoREST complex, the Nanog and Oct4 associated 
deacetylase (NODE) complex and the SHIP1 containing complex. HDACs complexes 
become associated with transcription factors through mediator proteins such as Sin3, NCoR, 
SMRT, CtBP and TLE [157]. Hdac1 and Hdac2 are important for embryonic development, 
especially during myogenesis, neurogenesis, haematopoiesis and epithelial cell 
differentiation [156]. The HDAC complexes NuRD and SIN3 are critical during different 
stages of embryonic development [158]. Mice embryos lacking Mbd3 or p66ǂ, components 
of the NuRD complex, die during embryonic development [159-160]. Mbd3 null mice show 
normal segregation of trophoblast and primitive endoderm, but fail to develop embryonic 
ectoderm and extraembryonic ectoderm [161]. ICM cells of these embryos continue 
expressing Oct4 and the primitive endoderm marker Gata4 and fail to expand in number. 
Further, even though the primitive endoderm is present, the visceral endoderm fails to form. 
Analogously, the ICM cells derived from Mbd3 null mice did not expand ex-vivo and mESCs 
could not be formed [161]. Mbd3 null mESCs could initiate differentiation but could not 
commit to the differentiated lineages [162]. Mbd3 was also shown to suppress trophoblast 
commitment of mESCs [163]. P66ǂ, however, was not required for proper blastocyst formation 
and implantation, and p66α null mice died later during embryogenesis [160]. Mi-2ǃ, another 
component of the NuRD complex, is important for haematopoiesis, lymphopoiesis and skin 
development [164-167]. Similar to Mbd3 and p66α, Sin3a null mice embryos also die after 
implantation [168-169]. The ICM derived from these embryos shows severely retarded 
proliferation ex vivo [168]. Sin3b null embryos show defects in erythrocyte and granulocyte 
maturation and in skeletal development [170]. The Class III HDACs, known as Sirtuins (SirTs), 
are also implicated during differentiation and mammalian development [171]. SirT1 is highly 
expressed in ESCs and decreases during differentiation [172]. During late development, SirT2 
modulates skeletal muscle and SirT1 modulates white adipose tissue differentiation [173-174]. 
Under oxidative stress, SirT1 causes astroglial differentiation in mouse neural progenitor cells 
[175]. SirtT2 controls gametogenesis in mice embryos [176]. 
3.2.3 Histone Methyltransferases 
Various Histone Methyltransferases (HMTs) exist in the mammalian genome and many 
putative HMTs are yet to be discovered [177]. The major mammalian HMTs include Ash1l, 
Dot1l, Ezh1-2, G9a, GLP, Mll1-5, Nsd1, Prdm1-6, Prdm8-16, PrSet7, Setd1-7, Setdb1-2, 
Setmar, Smyd1-5, Suv39h1-2, Suv4-20h1-2 and Whsc1/l1. Their requirement during specific 
stages of mammalian development is comprehensively reviewed in [177]. These HMTs are 
associated with specific histone methylation activities on H3 and H4 histones. Although 
most of identified methylation marks are promiscuous and need further study, some histone 
methylation marks correlate well with gene activity. Transcriptionally active genes display 
H3K4me3 on their promoter region and H3K36me3 across the gene body, while repressed 
genes are enriched in H3K27me3 over the gene body, with some amount of H3K9me3 and 
H4K20me3 [178-180]. H3K4 methylation, which is associated with gene activation, is 
induced by Mll1-5, Setd1a/b and Ash1l. Therefore, these HMTs are critical during 
mammalian development. Mutations in Mll1 lead to embryonic lethality in mice [181-182] 
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and cause aberrant regulation of Hox genes. Generation and/or expansion of hematopoietic 
stem cells, is abrogated in these embryos [183]. Mll2 null mice are capable of blastocyst 
formation and normal implantation without any lineage-specific growth abnormalities, but 
die later during embryonic development [184]. Very few genes are misregulated in Mll2 null 
mESCs, though Mll2 is needed for spermatogenesis [185]. Mll3 mutant mice show impaired 
differentiation towards the adipocyte lineage [186], while Mll5 mutant mice show impaired 
hematopoietic development [187]. H3K27 methylation, which is associated with gene 
repression and is important for embryonic development, is caused by the Ezh1-2 HTMs. 
Again, Ezh2 knockout causes early embryonic lethality in mouse embryos [188]. These 
embryos fail to complete gastrulation. Ezh2 is also shown to regulate epidermal and 
hematopoietic differentiation during embryogenesis [189-191]. H3K9 methylation is also 
associated with gene repression, and is induced by G9a, GLP, Prdm2, Setdb1 and Suv39h1-
2. No gene targets for the Suv39h enzymes have been discovered though Suv39h double 
mutant mice display impaired viability as well as sterility [192]. In contrast, Setdb1 knockout 
causes early embryonic lethality in mouse embryos due to aberrant blastocyst formation, 
and mESCs cannot be derived from these mutant blastocysts [193]. Setdb1 also controls the 
switch between osteoblastogenesis and adipogenesis from bone marrow mesenchymal 
progenitor cells [194]. Similar to Setdb1, both G9a and GLP null mice also show embryonic 
lethality, including aberrant somitogenesis and aberrant neural tube formation [195-196]. 
G9a inactivates ~120 genes during mESC differentiation including Oct4 and Nanog, in 
concert with DNA Methyltransferases Dnmt3a/b [197-198]. G9a is also implicated for 
genomic imprinting in the mouse placenta [199]. 
3.2.4 Histone Demethylases 
In humans, the identified histone demethylases include the KDM (Lysine (K) Demethylase) 
families of demethylases (KDM1-6), the PHF family and the JMJD6 family (reviewed in [200-
201]). As with histone methyltransferases, histone demethylases are critical for embryonic 
development. The KDM1 family comprises of KDM1A and KDM1B. Homozygous deletion 
mutants of Kdm1a are early embryonic lethal and do not gastrulate [202]. Kdm1a null ES cells 
are pluripotent but do not form embryoid bodies and do not differentiate [202]. Kdm1b 
mutant mice embryos are maternal embryonic lethal and defective in imprinting [203]. The 
KDM2 family comprises of KDM2A and KDM2B, of which, KDM2B is implicated in 
osteogenesis from mesenchymal stem cells [204]. The KDM3 family consists of KDM3A, 
KDM3B and JMJD1C. KDM3A is required for spermatogenesis [205-206]. KDM3A is 
positively regulated by Oct4 and depletion of KDM3A from ES cells leads to differentiation 
[207]. The KDM4 family consists of KDM4A, KDM4B, KDM4C and KDM4D, of which, 
KDM4C is also positively regulated by Oct4 [207]. Depletion of KDM4C causes 
differentiation in ES cells and KDM4C also positively regulates Nanog expression [207]. The 
KDM5 family comprises of KDM5A, KDM5B, KDM5C and KDM5D, of which, KDM5A has 
been implicated in differentiation [208]. The KDM6 family consists of KDM6A, UTY and 
KDM6B. KDM6A and KDM6B are shown to regulate HOX gene expression during 
development [209-210]. KDM6B also controls neuronal differentiation and epidermal 
differentiation [211-213]. The PHF family includes JHDM1D, PHF2 and PHF8, while the 
JMJD6 family includes only JMJD6. JHDM1D is required for neural differentiation in mESCs 
and knockdown of Jhdm1d blocks neural differentiation [214]. 
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3.2.5 DNA Methyltransferases 
The DNA Methyltransferases (DNMTs) in humans include DNMT1, DNMT2 and DNMT3 
(reviewed in [215-216]). The identified isoforms of DNMT1 are DNMT1s, DNMT1o, 
DNMT1b and DNMTΔE3-6. Members of DNMT3 are DNMT3a, DNMT3b and DNMT3L, of 
which, DNMT3a has isoforms DNMT3a1-4 and DNMT3b has isoforms DNMT3b1-8. Dnmt1 
null mice embryos die after gastrulation, before the 8-somite stage [217]. Double 
homozygous null mutations in Dnmt3a and Dnmt3b in mice embryos also caused similar 
phenotypes, with defects in neural tube closure and embryonic lethality at presomite stage 
[218-219]. During normal development, Dnmt3b is expressed in ICM, epiblast, embryonic 
ectoderm and spermatogonia of mouse embryo, whereas Dnmt3a is expressed throughout 
the embryo after E10.5 [220-221]. Dnmt3b is also expressed in progenitor population during 
hematopoiesis, spermatogenesis and neurogenesis [222]. During terminal neuronal 
differentiation, expression shifts to Dnmt3a [222]. Dnmt3l is required for genomic 
imprinting and female homozygous Dnmt3l null mice die during embryogenesis due to 
imprinting defects [223]. These mice show reduced spongiotrophoblast differentiation and 
excess trophoblast giant cell formation. Male homozygous Dnmt3l null mouse embryos 
show impaired spermatogenesis, but are viable [224]. Dnmt3a is also required for 
imprinting and spermatogenesis [225-226]. Curiously, triple homozygous knockout of 
Dnmt1, Dnmt3a and Dnmt3b causes no change in ESC self-renewal [227]. However, Dnmt1 
null ESCs with extremely low CpG methylation levels do not differentiate [228]. Similar 
blockage of differentiation is also observed in dual Dnmt3a/Dnmt3b homozygous null 
mutants [228]. 
3.2.6 Chromatin remodeling enzymes 
Chromatin remodeling enzymes are involved in controlling the higher order structure of 
chromatin by creating heterochromatin and euchromatin, and utilize the energy of ATP to 
do so. Chromatin remodeling enzymes thereby control cell fate during differentiation of 
ESCs (reviewed in [229]). During in vivo development, chromatin remodeling enzymes have 
been shown to be important for myeloid differentiation, erythropoiesis, T-cell development, 
adipogenesis, neurogenesis and myogenesis (reviewed in [230]). Mammalian chromatin 
modeling enzymes are categorized into three families: SWI/SNF, ISWI and CHD. The 
SWI/SNF family is characterized by the presence of either Brg1 or Brm as the catalytic 
subunit, and is further categorized into two subfamilies: Baf and Pbaf [231]. Brg1 
homozygous null mice die at peri-implantation stage and their ICM as well as trophoblast 
tissues die [232]. Similar phenotypes are observed homozygous mice null for Snf5, another 
subunit of SWI/SNF complexes [233]. However, downregulation of Baf60c causes late 
embryonic lethality due to defects in cardiac and skeletal muscle development [234]. Similarly, 
ablation of Baf180 leads to defects in heart development and placental trophectoderm 
development, and subsequent embryonic lethality [235] However, homozygous null 
mutations in Baf155 caused early embryonic lethality due to failure of ICM cells, though 
trophoblast giant cells were found to be normal [236]. Heterozygotes null for Baf155 showed 
defective brain development. In mESCs, knockdown of Brg1 leads to loss of self-renewal and 
impaired ability to differentiate to ectoderm and mesoderm [237]. Inactivation of Baf250b has 
been associated with reduced self-renewal and increased differentiation [238]. Interestingly, 
ablation of Baf250a caused failure of mesoderm formation in mouse embryos as well as in ESC-
based embryoid body cultures [239]. However, primitive endoderm differentiation and 
neuronal differentiation could be established in these cells. Brg1, Baf47, Baf155 and Baf57 are 
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required to suppress Nanog expression during differentiation and knockdown of Baf155 or 
Baf57 lead to de-repression of Nanog levels during differentiation [240].  
The ISWI family of chromatin remodelers is characterized by the presence of the Snf2h or Snf2l 
ATPase subunits that interact with unmodified histones. Snf2h is a part of the RSH, WICH, 
NoRC, CHRAC and ACF chromatin remodeling complexes. Snf2l is a part of the NURF and 
CERF complexes. Similar to Brg1, Snf2h homozygous null mice die at peri-implantation stage 
and both ICM and trophectoderm tissues degenerate [241]. Cecr2, a component of CERF, has 
been implicated in neural tube formation in mice [242]. Human NURF has also been 
implicated in neuronal development [243]. Interestingly, homozygous mice null for Bptf, a 
component of NURF, fail to form the visceral endoderm [244]. Bptf is required for ectoderm, 
mesoderm and both definitive and visceral endoderm development from ESCs in embryoid 
body cultures. Association between NURF complex and Smad transcription factors are 
necessary for endoderm formation [244]. The CHD family of chromatin remodelers is 
characterized by the presence of two chromodomains, with affinity for methylated histones. 
The CHD family is categorized into three subfamilies: family I with CHD1-2, family II with 
CHD3-4 and family III with CHD5-9. Downregulation of Chd1 in ESCs leads to impaired 
pluripotency, such that the cells are incapable of primitive endoderm and cardiac mesoderm 
differentiation and become prone to neural differentiation [245]. CHD3 and CHD4 are also 
found in NuRD histone deacetylase complexes described previously. Mutations in Chd7 are 
embryonic lethal, showing that Chd7 is also important for embryonic development [246]. 
3.2.7 Regulation of epigenetic factors by transcription factors 
Significant literature has been accumulated concerning the regulation of epigenetic factors 
by transcription factors. Transcription factors lie downstream of signaling pathways, raising 
the possibility that signaling pathways can control the recruitment of epigenetic factors to 
specific promoter regions. The vast number of interactions between the Smad transcription 
factors and epigenetic factors is extensively reviewed in [157]. Smads 1-4 can directly 
interact with HATs p300 and CBP [247] while Smads 2-3 can also interact with PCAF [248]. 
Smads 1, 2, 3 and 5 can interact with the HAT GCN5 [249] while Smad5 can also interact 
with the histone methyltransferases Suv39h2 [250]. Smad7 is acetylated and protected from 
degradation by p300 [251]. Smads 6 and 7 can also bind and recruit HDACs [252]. As 
discussed before, “bridging” proteins such as NCoR, Sin3, SMRT, CtBP and TLE can also 
help epigenetic factors to associate with transcription factors. Smad6 can directly bind CtBP 
[253]. Smads 3 and 4 can interact with NCoR and Sin3 through Dach1 [254]. Smad1 can also 
associate with Sin3a through Dach1 [255]. Smads 2, 3 and 4 can recruit NCoR as well as 
Sin3/HDAC through Ski [256-257]. Smad3 can associate with Hdac1 through TGIF2 [258]. 
Similarly, the transcription factor ǃ-catenin can recruit epigenetic factors and influence the 
epigenetic state of cells (reviewed in [64]). ǃ-catenin can associate with the HATs p300 and 
CBP [259-260] as well as TIP60 [261]. ǃ-catenin can also associate with the chromatin 
remodeling factors Brg1 and ISWI [64]. Additionally, ǃ-catenin can interact with the histone 
methyltransferases Mll1/Mll2 [261]. The Erk kinase, which is downstream of the MAPK 
pathway, can phosphorylate CBP [262], Smads 1-4 [263-265] as well as Brg1 and Brm [266]. 
Similarly, the Akt kinase, which is downstream of PI3K signaling, can associate with 
SWI/SNF components Ini1, Baf155 and Baf170, and can phosphorylate Baf155 [267]. Akt can 
interact with the histone methyltransferases Setdb1 [268] and Ezh2 and can phosphorylate 
and inhibit Ezh2 [269]. Akt can also phosphorylate and activate p300 [270]. Interestingly, the 
pluripotency factor Oct4 has also been shown to associate with numerous epigenetic factors 
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including components of the NuRD HDAC complex (Chd4, p66ǂ, p66ǃ, Mbd3, Mta1-3 and 
Hdac1), chromatin remodeling proteins (Brg1, Baf155 and ISWI) and DNA 
methyltransferases (Dnmt3a and Dnmt3l) [271]. 
3.3 Cell polarity 
Cell polarity is a feature of cellular physiology exhibited by epithelial cells. It refers to 
uneven spatial distribution of proteins across the cell, causing different parts of the cell to 
have different morphology and functions. Cell polarity can be classified as apical-basal 
polarity (epithelial cells), anterior-posterior polarity (neurons) and planar polarity (cochlea). 
In mammals, the apical-basal polarity of epithelial cells is regulated by three distinct protein 
complexes: the Crumbs/PALS1/PATJ complex, the Par3/Par6/aPKC complex and the 
Scribble/Dlg/Lgl complex. A detailed review of these complexes and their function in 
controlling epithelial architecture, cell migration and tumorigenesis can be found in [272]. 
The apical-basal polarity is lost during epithelial-to-mesenchymal transformation (EMT), a 
process that changes epithelial cells to mesenchymal cells with no apical-basal polarity and 
occurs during embryogenesis, fibrosis and cancer metastasis. Importantly, recent findings 
have indicated that epithelial cell polarity is required for early mouse embryogenesis and 
may be the driving factor for differentiation of certain early lineages. For example, the cell 
polarity regulator Par6 is required for proper trophectoderm formation in mouse embryos 
[273]. Downregulation of Par3 or aPKC drives blastomeres towards ICM instead of 
trophectoderm [274]. Interestingly, the Crumbs polarity complex has been found to interact 
with components of the Hippo signaling pathway [99], and the Hippo has been implicated 
in trophectoderm formation as discussed in the review. It will therefore be interesting to 
study whether cell polarity proteins indeed control trophectoderm differentiation during 
early stages of embryogenesis. 
4. Conclusions 
The development and morphogenesis of the embryo is under strict control by a rather small 
set of signaling pathways. However, the presence of multiple ligands and multiple receptors, 
numerous transcription factor-binding partners and significant crosstalk between pathways 
gives rise to vast complexity within this small set of signaling pathways. Further, lineage-
specific differentiation is also controlled by complex regulation of various histone 
acetyltransferases, histone deacetylases, histone methyltransferases, histone demethylases, 
DNA methyltransferases and chromatin-remodeling enzymes. A detailed and molecular-level 
understanding of the determinants of lineage specificity of differentiation has only recently 
begun to emerge through studies of the signaling pathways and their downstream factors. We 
have summarized the signaling pathways and miRNAs associated with differentiation to 
various lineages in Table 1. Along similar lines, various histone modifying proteins and 
chromatin remodeling proteins associated with various lineages are summarized in Table 2. 
Even though these tables present a concise mechanistic linkage between various regulators of 
ESC differentiation, questions regarding how lineage-specific transcription factors are 
regulated and how a balance between opposing factors, such as HATs and HDACs, or HMTs 
and histone demethylases, is achieved in the cell remain largely unanswered. Further, the 
possible role of lineage-specific transcription factors in the recruitment of epigenetic factors 
also remains largely unknown. Thus, our understanding of the lineage-specificity of 
differentiation is still rudimentary and requires significant additional research. 
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 Link with Lineage-specific 
Transcription Factors 
Smad2/3 activates Nanog promo
Nanog binds and inhibits Smad1[275] 
 
Smad1/5/8 binds  Nanog promo
Wnt3a activates Brachyury [67] 
ǃ-catenin regulates Cripto promo
Wnt3a activates Brachyury [67] 
Smad1/5/8 binds  Nanog promo
 
Smad1/5/8 binds Nanog promot
[25]d2 activates Pax3 promoter [101] 
Smad1/5/8 binds  Nanog promo
Ras/MAPK upregulates Cdx2 [42]
Yap and Tead4 coactivate Cdx2 [98]
 
FGF controls Runx1, Lmo2, Scl [50]
 
 
Signaling Pathways 
Activin/Nodal [23-24] 
FGF [24, 38-39, 54-55] 
Block Activin/Nodal [12, 14] 
Low Activin/Nodal [13, 18-19] 
Short-term BMP [18-19, 27] 
FGF [44-47], Wnt [66, 68-69, 73] 
High Activin/Nodal [13, 17, 20-21] 
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High BMP [15] 
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FGF [51, 53, 57, 60] 
Block Activin/Nodal [12, 14] 
Low BMP [16], FGF [51, 57] 
Hippo [101] (?) 
Block Activin/Nodal [26] 
Long-term BMP[27-28] 
FGF [40-42, 56], Hippo [98] 
FGF [40, 43] 
FGF [48-49] 
Block Wnt [74] 
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Epigenetic Factors 
Chromatin 
Remodeling
Brg1 [232] 
Baf155 [236]
Baf250b [238] 
Snf2h [241] 
Brg1 [237] 
NURF [244] 
Brg1 [237] 
Baf250a [239]
NURF [244] 
NURF [244] 
 
Baf155 [236]
Snf2l [242-243]
Brg1 [232] 
Baf180 [235]
Snf2h [241] 
 
Baf60c [234]
Baf180 [235]
CHD1 [245]
 
Baf60c [234]
CHD1 [245]
DNMT 
 
 
 
 
Dnmt3l 
[224] 
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Dnmt3b 
[218-219] 
Dnmt3l 
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